Loading…

Irritable bowel syndrome: Factors of importance for disease‐specific quality of life

BACKGROUND: Irritable bowel syndrome patients report reduced disease‐specific quality of life (IBSQOL). Factors of potential relevance for QOL include gastrointestinal (GI), psychological, and somatic symptoms, demographics, and GI motor and sensory abnormalities. OBJECTIVE: The aim of our study was...

Full description

Bibliographic Details
Main Authors:	Melchior, Chloé, Colomier, Esther, Trindade, Inês A., Khadija, Mahrukh, Hreinsson, Jóhann P., Törnblom, Hans, Simrén, Magnus
Format:	Online Article Text
Language:	English
Published:	John Wiley and Sons Inc. 2022
Subjects:	Neurogastroenterology
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703939/ https://www.ncbi.nlm.nih.gov/pubmed/35830193 http://dx.doi.org/10.1002/ueg2.12277

Similar Items

Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management
by: Melchior, Chloé, et al.
Published: (2022)

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
by: Tornkvist, Navkiran T., et al.
Published: (2021)

Association between Brachyspira and irritable bowel syndrome with diarrhoea
by: Jabbar, Karolina S, et al.
Published: (2021)

Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome
by: Algera, Joost P., et al.
Published: (2022)

Work productivity and activity impairment in disorders of gut‐brain interaction: Data from the Rome Foundation Global Epidemiology Study
by: Frändemark, Åsa, et al.
Published: (2023)

Worldwide prevalence and burden of gastroparesis‐like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis
by: Huang, I‐Hsuan, et al.
Published: (2022)

Disorders of gut‐brain interaction: Highly prevalent and burdensome yet under‐taught within medical education
by: Simons, Julia, et al.
Published: (2022)

European guidelines on functional bowel disorders with diarrhoea: United European Gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) statements and recommendations
by: Tornkvist, Navkiran T., et al.
Published: (2022)

Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndrome
by: Henström, Maria, et al.
Published: (2018)

Epithelial expression and function of trypsin-3 in irritable bowel syndrome
by: Rolland-Fourcade, Claire, et al.
Published: (2017)

Gut-focused hypnotherapy for children and adolescents with irritable bowel syndrome
by: Vasant, Dipesh H, et al.
Published: (2020)

Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome‐wide association study
by: Seeling, Katharina Sophie, et al.
Published: (2023)

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
by: Garsed, Klara, et al.
Published: (2014)

Gastric emptying rate and relevance for symptoms
by: Törnblom, Hans
Published: (2023)

A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome
by: Weerts, Zsa Zsa R. M., et al.
Published: (2021)

Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit
by: Tooth, David, et al.
Published: (2014)

Irritable bowel syndrome and risk of glaucoma: An analysis of two independent population‐based cohort studies
by: McPherson, Zachary E., et al.
Published: (2021)

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain
by: Akbar, A, et al.
Published: (2008)

Construction and validation of a questionnaire distinguishing a chronic abdominal wall pain syndrome from irritable bowel syndrome
by: van Assen, Tijmen, et al.
Published: (2012)

Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study
by: McEvoy, Mark A., et al.
Published: (2021)

Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice
by: Noble, Hithin, et al.
Published: (2022)

The gastrointestinal tract in hunger and satiety signalling
by: Tack, Jan, et al.
Published: (2021)

Assessing telephone-delivered cognitive–behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial
by: Everitt, Hazel Anne, et al.
Published: (2019)

Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome
by: Colomier, Esther, et al.
Published: (2022)

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility
by: Savarino, Edoardo, et al.
Published: (2022)

The effectiveness of rotating versus single course antibiotics for small intestinal bacterial overgrowth
by: Richard, Nicolas, et al.
Published: (2021)

Interferential therapy for chronic constipation in adults: The CON‐COUR randomizedcontrolled trial
by: Vitton, Veronique, et al.
Published: (2023)

Inflammatory bowel disease psychological support pilot reduces inflammatory bowel disease symptoms and improves psychological wellbeing
by: Eccles, Jessica Anne, et al.
Published: (2020)

Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
by: Colomier, Esther, et al.
Published: (2021)

The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence
by: Algera, Joost, et al.
Published: (2019)

Identification of bacterial lipopeptides as key players in IBS
by: Petitfils, Camille, et al.
Published: (2023)

Global prevalence and burden of meal-related abdominal pain
by: Colomier, Esther, et al.
Published: (2022)

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia
by: Wauters, Lucas, et al.
Published: (2021)

Maintaining work life under threat of symptoms: a grounded theory study of work life experiences in persons with Irritable Bowel Syndrome
by: Frändemark, Åsa, et al.
Published: (2022)

European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus
by: Hammer, Heinz F., et al.
Published: (2021)

Type of Rectal Barostat Protocol Affects Classification of Hypersensitivity and Prediction of Symptom Severity in Irritable Bowel Syndrome
by: Josefsson, Axel, et al.
Published: (2022)

Randomised clinical trial and meta‐analysis: mesalazine treatment in irritable bowel syndrome—effects on gastrointestinal symptoms and rectal biomarkers of immune activity
by: Castro Tejera, Valeria, et al.
Published: (2022)

miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea
by: Martínez, Cristina, et al.
Published: (2017)

Close follow‐up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long‐term management of eosinophilic esophagitis
by: Bon, Lorenz, et al.
Published: (2022)

Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome
by: Lövdahl, Jenny, et al.
Published: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g4urj5pfbtdpe0rdarh8c4pfn7